Recalls / Class II
Class IID-0130-2019
Product
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450
- Affected lot / code info
- Lot# 04042018:58, Exp 10/17/18
Why it was recalled
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Recalling firm
- Firm
- RXQ Compounding LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 340 W State St Unit 9, N/A, Athens, Ohio 45701-1564
Distribution
- Quantity
- 395 vials
- Distribution pattern
- U.S.A. nationwide
Timeline
- Recall initiated
- 2018-09-25
- FDA classified
- 2018-11-01
- Posted by FDA
- 2018-10-31
- Terminated
- 2022-10-18
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0130-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.